These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32910207)

  • 1. Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a meta-analysis.
    Wang S; Yuan B; Wang Y; Li M; Liu X; Cao J; Li C; Hu J
    Int J Colorectal Dis; 2021 Jan; 36(1):117-130. PubMed ID: 32910207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis.
    Ni X; Sun X; Wang D; Chen Y; Zhang Y; Li W; Wang L; Suo J
    Clin Transl Oncol; 2019 May; 21(5):674-686. PubMed ID: 30392153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis.
    He J; Chen XF; Xu MG; Zhao J
    Arch Oral Biol; 2020 Jun; 114():104717. PubMed ID: 32344357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Analysis of Positive PD-L1 Expression and Clinicopathological Features and Survival Prognosis in Patients with Colorectal Cancer: Systematic Review and Meta-Analysis.
    Tang M; Zheng Z; Shang J; Zhang S
    J Healthc Eng; 2022; 2022():8212486. PubMed ID: 35449848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a systematic review and meta-analysis.
    Shen Z; Gu L; Mao D; Chen M; Jin R
    World J Surg Oncol; 2019 Jan; 17(1):4. PubMed ID: 30609938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 Overexpression on Tumor-Infiltrating Lymphocytes Related to Better Prognosis of Colorectal Cancer.
    Wang JL; Yu T; Sun TT; Feng Y; Xiong H; Fang JY
    Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Li Y; He M; Zhou Y; Yang C; Wei S; Bian X; Christopher O; Xie L
    Front Pharmacol; 2019; 10():139. PubMed ID: 30873025
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis.
    Yang L; Xue R; Pan C
    Onco Targets Ther; 2019; 12():3671-3682. PubMed ID: 31190869
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma: A systematic review and meta-analysis.
    Huang LJ; Deng XF; Chang F; Wu XL; Wu Y; Diao QZ
    Medicine (Baltimore); 2018 Oct; 97(43):e12858. PubMed ID: 30412078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
    Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
    Front Immunol; 2018; 9():2077. PubMed ID: 30254644
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis.
    Xian F; Ren D; Bie J; Xu G
    Front Immunol; 2023; 14():1119168. PubMed ID: 37138876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral Cytotoxic T-Lymphocyte Density and PD-L1 Expression Are Prognostic Biomarkers for Patients with Colorectal Cancer.
    Calik I; Calik M; Turken G; Ozercan IH; Dagli AF; Artas G; Sarikaya B
    Medicina (Kaunas); 2019 Oct; 55(11):. PubMed ID: 31683723
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic and Clinicopathological Value of PD-L1 in Melanoma: A Meta-Analysis.
    Xu J; Wang F; Yan Y; Zhang Y; Du Y; Sun G
    Am J Med Sci; 2020 Jun; 359(6):339-346. PubMed ID: 32498941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.
    Li XS; Li JW; Li H; Jiang T
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32255189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sidedness of colorectal cancer on tumor immunity.
    Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
    PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed death-ligand 1 and survival in colorectal cancers: A meta-analysis.
    Cao H; Wang Q; Gao Z; Yu Z; Wu Y; Lu Q
    Int J Biol Markers; 2019 Dec; 34(4):356-363. PubMed ID: 31564188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients.
    Shen H; Liu J; Sun G; Yan L; Li Q; Wang Z; Xie L
    Aging (Albany NY); 2020 Dec; 13(2):2279-2293. PubMed ID: 33318295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.
    Li J; Wang P; Xu Y
    PLoS One; 2017; 12(6):e0179536. PubMed ID: 28604812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between programmed cell death ligand 1 expression and thyroid cancer: A meta-analysis.
    Wan B; Deng P; Dai W; Wang P; Dong Z; Yang C; Tian J; Hu T; Yan K
    Medicine (Baltimore); 2021 Apr; 100(14):e25315. PubMed ID: 33832105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.